Opdualag European Union - Lithuanian - EMA (European Medicines Agency)

opdualag

bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanoma - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.

Spevigo European Union - Lithuanian - EMA (European Medicines Agency)

spevigo

boehringer ingelheim international gmbh - spesolimab - psoriazė - imunosupresantai - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.

DEXAMETHASONE PHOSPHATE MEDOCHEMIE Lithuania - Lithuanian - SMCA (Valstybinė vaistų kontrolės tarnyba)

dexamethasone phosphate medochemie

medochemie ltd. - deksametazono natrio fosfatas - injekcinis ar infuzinis tirpalas - 4 mg/ml - dexamethasone

Epysqli European Union - Lithuanian - EMA (European Medicines Agency)

epysqli

samsung bioepis nl b.v. - eculizumab - hemoglobinurija, paroksizminis - imunosupresantai - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.

Columvi European Union - Lithuanian - EMA (European Medicines Agency)

columvi

roche registration gmbh  - glofitamab - lymphoma, large b-cell, diffuse - antinavikiniai vaistai - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.

Resthizen Lithuania - Lithuanian - SMCA (Valstybinė vaistų kontrolės tarnyba)

resthizen

zenthique limited - klaritromicinas - milteliai infuzinio tirpalo koncentratui - 500 mg - clarithromycin

Tevimbra European Union - Lithuanian - EMA (European Medicines Agency)

tevimbra

novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - antinavikiniai vaistai - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.

Atracurium besilate Kalceks Lithuania - Lithuanian - SMCA (Valstybinė vaistų kontrolės tarnyba)

atracurium besilate kalceks

as kalceks - atrakurio besilatas - injekcinis ar infuzinis tirpalas - 10 mg/ml - atracurium

Primovist Lithuania - Lithuanian - SMCA (Valstybinė vaistų kontrolės tarnyba)

primovist

bayer ag - gadokseto rūgštis - injekcinis tirpalas užpildytame švirkšte - 0,25 mmol/ml - gadoxetic acid

Propofol-Lipuro Lithuania - Lithuanian - SMCA (Valstybinė vaistų kontrolės tarnyba)

propofol-lipuro

b.braun melsungen ag - propofolis - injekcinė ar infuzinė emulsija - 20 mg/ml; 10 mg/ml - propofol